Picardi, M., & Giordano, C. (2021). Comment on “Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: The phase II HOVON/LLPC Transplant BRaVE study.”. Haematologica.
استشهاد بنمط شيكاغوPicardi, Marco, و Claudia Giordano. "Comment On “Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine and Cisplatin As Salvage Treatment in Relapsed or Refractory Hodgkin Lymphoma: The Phase II HOVON/LLPC Transplant BRaVE Study.”." Haematologica 2021.
MLA استشهادPicardi, Marco, و Claudia Giordano. "Comment On “Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine and Cisplatin As Salvage Treatment in Relapsed or Refractory Hodgkin Lymphoma: The Phase II HOVON/LLPC Transplant BRaVE Study.”." Haematologica 2021.